Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer-Reference-Cited by-同舟云学术

Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer

Published:2006 Issue:7 Volume:107 Page:1459-1466
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Rouzier Roman,Pusztai Lajos,Garbay Jean-Remi,Delaloge Suzette,Hunt Kelly K.,Hortobagyi Gabriel N.,Berry Donald,Kuerer Henry M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference22 articles.

1. Proceedings of the Consensus Conference on Neoadjuvant Chemotherapy in Carcinoma of the Breast, April 26-28, 2003, Philadelphia, Pennsylvania

2. Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis

3. Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors

4. A prospective trial of preoperative chemotherapy in resectable breast cancer: Predictors of breast-conservation therapy feasibility

5. Nomograms as predictive models

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Nomogram Based on Nutrition-Related Indicators and Computed Tomography Imaging Features for Predicting Preoperative Lymph Node Metastasis in Curatively Resected Esophagogastric Junction Adenocarcinoma;Annals of Surgical Oncology;2023-04-03

2. A novel nomogram based on clinical blood indicators for prognosis prediction in curatively resected esophagogastric junction adenocarcinoma patients;Journal of Cancer;2023

3. Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer;Journal of Breast Cancer;2023

4. Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response after Neoadjuvant Chemotherapy in Breast Cancer: model development using commonly available clinical and demographic variables;2022-09-20

5. Désescalade thérapeutique dans le cancer du sein en chirurgie oncologique;Bulletin du Cancer;2021-12